Information
Learning Objective 1
Describe at least three different types of gene-targeting therapies being explored in monogenic epilepsies
Learning Objective 2
Demonstrate understanding of potential disease-specific outcome measures for clinical trials
Learning Objective 3
Identify challenges in implementation of novel therapies in a rare disease population
Target Audience
CliniciansFellows/TraineesAdvanced Practice Providers (APPs)AdvocatesBehavioral Health ProvidersCommunity Health WorkersNursesPharmacistsScientists/ResearchersSocial WorkersTechnicians
Career Stage
Early Career (typically 0-5 years from completion of training)Mid-Career (typically 6-15 years from completion of trainingSenior (typically >15 years from completion of training)
Demographics
ClinicalFirst-time AttendeesYoung ProfessionalsResearch
Session Content Includes
and Inclusion (DEI)DiversityEquityPediatric
Education Credits
2.5 CME2.5 CNE2.5 CPE
Session ID
SCISYMP26
Presentation Id
3451823
Event ID
24056
Session Type
Session

